Healing
Cartalax
Longevity
3
Amino acids
Molecular weight
Peptide
Type
Synthetic tripeptide developed by Professor Vladimir Khavinson, supporting cartilage, connective tissue, and cellular regeneration through proliferation markers and apoptosis pathway modulation.
Top researched benefits
Overview of Cartalax
Modulates cell proliferation, suppresses apoptosis, affects fibroblast activity, reduces senescence markers, and influences extracellular matrix preservation.
Joint Health
- Clinical efficacy shown in osteochondrosis, osteoarthritis, and osteoporosis treatment.
- Supports cartilage maintenance and joint function.
- Supports bone and connective tissue healing.
Skin Health
- Increased Ki-67 expression with suppressed apoptosis in young and aged cells.
- Enhances collagen synthesis in connective tissue.
- Inhibited MMP-9 synthesis; maintained extracellular matrix integrity.
Storage
Oral capsules: room temperature; Injectable lyophilized: 2-8°C; Reconstituted: 2-8°C refrigerated
Frequency
1-2 times daily with meals (oral) or once daily (injectable)
Typical Dose
100-200mcg oral (1-2 capsules) or 700-1400mcg injectable
Cycle Duration
1-3 months depending on application
Chemical Makeup
Key benefits
Joint and connective tissue support
Potential anti-aging effects on fibroblasts
Cartilage regeneration support
Established safety profile in Russian clinical practice
Community interest
This peptide is still gaining traction in the community.
Bioregulatory Tripeptide | Cartilage & Connective Tissue Support
This overview is informational and based on aggregated descriptions from studies and user reports.
Was it helpful?YesCartalax Molecular Information
View the scientifc details of Cartalax.
3
Amino Acids
Cartalax
Ala
Ala
Position 1
Glu
Glu
Position 2
Asp
Asp
Position 3
Molecular Weight
333.29DaChain Length
3Amino AcidsType
PeptideCartalax Protocols
Capsule form; do not chew, swallow whole with water during meals.
| Goal | Dosage | Frequency | Route |
|---|---|---|---|
| Joint Support | 100 | 1 week range | Oral |
Cartalax Cycle
The Cartalax Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.
Taking breaks between cycles may help maintain effectiveness and support better overall results.
- Week 1-2
- Establishing baseline; minimal noticeable changes
- Week 3-4
- Gradual improvement in joint comfort
- Week 0-0
- Noticeable mobility improvements
- Week 0-0
- Maximum therapeutic effect achieved
Dosing tools
Cartalax Peptide Dosage Calculator
Calculate peptide doses with our visual syringe guide.
0.3mL / 30 units
5 units
0.050 mL
1 mL
2 mL
3 mL
5 mL
Custom
Conversion: 1,000 mcg = 1 mg
Injection Results
Based on your vial and dilution inputs.
Safe concentration range
Cartalax
SINGLE COMPOUNDVolume per injection
0.05
mL
Concentration
10.00
mg/mL
Doses per vial
20
doses
Total injections per vial
20 injections
How it works
Based on a 10 mg Cartalax vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.
Research Purposes Only
These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.
Reference Guide
Dosing Cycle
- Peptide
- Cartalax
- Dosing
- 100-200mcg oral (1-2 capsules) or 700-1400mcg injectable
- Dosing Frequency
- 1-2 times daily with meals (oral) or once daily (injectable)
- Cycle Duration
- 1-3 months depending on application
- Storage
- Oral capsules: room temperature; Injectable lyophilized: 2-8°C; Reconstituted: 2-8°C refrigerated
Note: Triple agonist; microdose for fewer side effects
Reconstitution Tips
- Use bacteriostatic water (BAC) — contains 0.9% benzyl alcohol for preservation
- Inject water slowly — aim down the vial wall, not directly onto powder
- Never shake — gently swirl or roll the vial until dissolved
- Store properly — refrigerate at 2-8°C after reconstitution
- Use within 28 days — most reconstituted peptides remain stable for about 4 weeks
- Keep sterile — always clean vial tops with alcohol before drawing
Peptide Interactions
Research suggestions of Cartalax interactions with other common peptides and substances.
Side effects
Contraindications
Pregnancy and breastfeeding
Active cancer (theoretical proliferation risk)
Stop signs
Allergic reactions
Digestive upset (rare with proper administration)
No improvement after 3 months
Unexpected symptoms
Bad signs
Comments
0.0
0 reviews
5
4
3
2
1
No comments yet
Be the first to share your experience. Your review helps others make more informed decisions.
Frequently asked questions
What benefits can peptides offer in research?
Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.
What are some exciting applications of peptides in modern science?
Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.
How do peptides influence health and wellness?
Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.
Where can I find the latest studies on peptide applications?
Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.
Are there any guidelines for using peptides in research?
Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.
What is the difference between peptides and proteins?
Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.
How should peptides be stored?
Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.
Can peptides be taken orally?
Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.
CartalaxResearch References
Cartalax is an emerging compound
Cartalax
Cartalax is an emerging compound
Fibroblast Proliferation Study
Human skin fibroblasts; 72 hours at 20 nM. Increased Ki-67 expression with suppressed apoptosis in young and aged cells.
2019
Kidney Cell Culture Research
Renal epithelial cells; 7 days. Reduced pro-apoptotic p53 expression in aging kidney cells.
2020
Clinical Spine & Joint Study (Russia)
Human subjects; 1-3 months with 0.1mg capsules daily. Efficacy in osteochondrosis, osteoarthritis, and osteoporosis treatment.
n.d.
Matrix Metalloproteinase Research
Fibroblast cultures; 5 days at 20 nM. Inhibited MMP-9 synthesis; maintained extracellular matrix integrity.
2020